A Japanese health ministry panel has endorsed two products using iPS cells, paving the way for the world's first practical ...

The iPSC-derived NK cells clinical trial analysis report delivers important insights into ongoing research of 15+ pipeline iPSC-derived NK cells drugs, clinical strategies, upcoming therapeutics, and ...

Japanese government experts endorsed on Thursday ground-breaking projects to manufacture regenerative medicine products to ...

A panel of experts on Thursday gave the green light for the health minister to approve the production and sale of two ...

The earliest they are likely to become available is around summer, after drug pricing has been finalized. These products will be covered by the public health insurance system. The out-of-pocket burden ...

Drugs made with iPS, or induced pluripotent stem cells, will be used to treat patients with severe heart failure and Parkinson's disease Japan's health ministry panel on Thursday approved the ...

Three lines of GMP iPS Cells derived from type O female blood are now offered as off-the-shelf product It is well known that HLA homozygous iPSCs are often selected to reduce adverse immune response ...

Induced pluripotent stem cells (iPSCs) are a “starting material grail” for advanced therapies. That’s according to Sven Kili, chief development officer at CCRM, the Canadian regenerative medicine ...

King's College London researchers have created a unique collection of human stem cell models that could help to uncover why ...

The fact that the researchers replaced retroviruses with adenoviruses is an important step, added Brivanlou, but adenoviruses still can integrate into the genome, albeit rarely. In order for iPS cells ...

TOKYO, Japan - Japanese government experts endorsed on Thursday ground-breaking projects to manufacture regenerative medicine ...